Sickle Cell Disease | CHOP Research Institute
 

Sickle Cell Disease

Published on
May 13, 2025
Scientists, staff, and students from CHOP and the University of Pennsylvania community celebrated the next generation of pediatric researchers and the continuation of collaborative scientific discovery at the Poster Day and Scientific Symposium.
Published on
Mar 7, 2025
STAT Madness selects CHOP-led research on hemophilia A gene therapy for the bracket competition, and two scientists are nominated as "Disruptors of the Year."
Published on
Dec 11, 2024
The National Academy of Medicine elects Alexis Thompson, MD, MPH, for her significant contributions to sickle cell disease research.
Published on
Nov 27, 2024
A study funded by the National Heart, Lung, and Blood Institute aims to improve blood transfusion outcomes.

Dr. Prussien’s work focuses on utilizing biopsychosocial methods to improve health equity for individuals living with sickle cell disease (SCD). Specifically, her work examines how structural and interpersonal racism influences SCD through physiological stress and behavioral responses.

E-mail:
prussienkv [at] chop.edu
Published on
Apr 26, 2024
News highlights this week include the Biomedical Technician Training Program recognition event, new COVID-19 outcomes research, and more.
Published on
Mar 15, 2024
This week, CHOP announces two new Frontier Programs, and researchers define the origins of hematopoietic failure in Fanconi anemia.
Published on
Jan 3, 2024
After decades of limited progress in treating sickle cell disease, we have reached an historical moment with two new gene therapies.
Published on
Dec 22, 2023
Our research news roundup highlights newly approved gene therapies, insights into common genetic epilepsy disorders, and head injury prevention for young athletes.
Published on
Dec 8, 2023
Our research news roundup highlights the improvements made in CAR therapies through structural biology discoveries and cost reduction strategies.